We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

Nasdaq:DNLI

Denali Therapeutics Inc. (DNLI)

Nasdaq • DNLI • US24823R1059

20.96Last close

Market Closed

Trading Signals

ORTEX Data Highlights

As of Nov 3, 2026, ORTEX estimates 9.7% of free float is sold short, 9.2 days to cover, cost to borrow 0.5%.

Market Cap

3.36b USD | # 3125 in US

Volume

1.64m shares | 34.98m USD

Shares Outstanding

159.85m

Free Float Shares

97.03% | 155.09m

DB:4DN|

BOVESPA:D2NL34

News

DNLI key data

Denali Therapeutics Inc. (Nasdaq: DNLI) has a market capitalization of $3.36B. Last close $20.96 (as of 2026-11-05); 52-week range $13.75 to $27.30. ORTEX data as of 2026-11-03: short interest is 9.74% of free float, 9.2 days to cover and the average cost to borrow is 0.5%.

DNLI news on ORTEX News
ORTEX News
ORTEX public data
ORTEX Charts
ORTEX API

© 2026 ORTEX Technologies Ltd.